Enavate Launches With $300m To Help Drug Developers Get Over Funding Hurdles

Patient Square Is Sole Initial Investor

 
• By Mandy Jackson
Businessman jumping on chart columns
Growing companies face a chilly market, which is where Enevate hopes to step in • Source: Alamy

More from Financing

More from Business